X-chromosome inactivation analysis in a female carrier of FOXP3 mutation

A. Tommasini, S. Ferrari, D. Moratto, R. Badolato, M. Boniotto, D. Pirulli, L. D. Notarangelo, M. Andolina

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Immune dysregulation, polyendocrinopathy and enteropathy with X-linked inheritance (IPEX) is a serious disease arising from mutations in FOXP3. This gene codifies for a transcription factor whose dysfunction results in hyperactivation of T cells. It is not clear, however, why an intermediate phenotype is not seen in heterozygous females, who are completely healthy. In order to address this question, we investigated X-chromosome inactivation in peripheral blood lymphocytes from a heterozygous female with a child affected by IPEX. No preferential inactivation was shown in freshly sorted CD4+, CD8+, CD19+ cells or in IL-2 cultured CD4 and CD8 T cells, indicating that peripheral blood lymphocytes in these women are randomly selected. Moreover, only one single FOXP3 transcript was expressed by CD4 T cell clones analysed by RT-PCR, confirming that this gene is subject to X-inactivation. We hypothesize that hyper-activation of T cell in carriers of FOXP3 mutations is regulated by the presence of normal regulatory T cells.

Original languageEnglish
Pages (from-to)127-130
Number of pages4
JournalClinical and Experimental Immunology
Volume130
Issue number1
DOIs
Publication statusPublished - 2002

Fingerprint

X Chromosome Inactivation
T-Lymphocytes
Mutation
Lymphocytes
X-Linked Genes
Regulatory T-Lymphocytes
Genes
Interleukin-2
Transcription Factors
Clone Cells
Phenotype
Polymerase Chain Reaction

Keywords

  • FOXP3
  • IPEX
  • T lymphocytes
  • X-chromosome inactivation

ASJC Scopus subject areas

  • Immunology

Cite this

Tommasini, A., Ferrari, S., Moratto, D., Badolato, R., Boniotto, M., Pirulli, D., ... Andolina, M. (2002). X-chromosome inactivation analysis in a female carrier of FOXP3 mutation. Clinical and Experimental Immunology, 130(1), 127-130. https://doi.org/10.1046/j.1365-2249.2002.01940.x

X-chromosome inactivation analysis in a female carrier of FOXP3 mutation. / Tommasini, A.; Ferrari, S.; Moratto, D.; Badolato, R.; Boniotto, M.; Pirulli, D.; Notarangelo, L. D.; Andolina, M.

In: Clinical and Experimental Immunology, Vol. 130, No. 1, 2002, p. 127-130.

Research output: Contribution to journalArticle

Tommasini, A, Ferrari, S, Moratto, D, Badolato, R, Boniotto, M, Pirulli, D, Notarangelo, LD & Andolina, M 2002, 'X-chromosome inactivation analysis in a female carrier of FOXP3 mutation', Clinical and Experimental Immunology, vol. 130, no. 1, pp. 127-130. https://doi.org/10.1046/j.1365-2249.2002.01940.x
Tommasini, A. ; Ferrari, S. ; Moratto, D. ; Badolato, R. ; Boniotto, M. ; Pirulli, D. ; Notarangelo, L. D. ; Andolina, M. / X-chromosome inactivation analysis in a female carrier of FOXP3 mutation. In: Clinical and Experimental Immunology. 2002 ; Vol. 130, No. 1. pp. 127-130.
@article{e051ff0ec4384ab198b38f4f97982da6,
title = "X-chromosome inactivation analysis in a female carrier of FOXP3 mutation",
abstract = "Immune dysregulation, polyendocrinopathy and enteropathy with X-linked inheritance (IPEX) is a serious disease arising from mutations in FOXP3. This gene codifies for a transcription factor whose dysfunction results in hyperactivation of T cells. It is not clear, however, why an intermediate phenotype is not seen in heterozygous females, who are completely healthy. In order to address this question, we investigated X-chromosome inactivation in peripheral blood lymphocytes from a heterozygous female with a child affected by IPEX. No preferential inactivation was shown in freshly sorted CD4+, CD8+, CD19+ cells or in IL-2 cultured CD4 and CD8 T cells, indicating that peripheral blood lymphocytes in these women are randomly selected. Moreover, only one single FOXP3 transcript was expressed by CD4 T cell clones analysed by RT-PCR, confirming that this gene is subject to X-inactivation. We hypothesize that hyper-activation of T cell in carriers of FOXP3 mutations is regulated by the presence of normal regulatory T cells.",
keywords = "FOXP3, IPEX, T lymphocytes, X-chromosome inactivation",
author = "A. Tommasini and S. Ferrari and D. Moratto and R. Badolato and M. Boniotto and D. Pirulli and Notarangelo, {L. D.} and M. Andolina",
year = "2002",
doi = "10.1046/j.1365-2249.2002.01940.x",
language = "English",
volume = "130",
pages = "127--130",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - X-chromosome inactivation analysis in a female carrier of FOXP3 mutation

AU - Tommasini, A.

AU - Ferrari, S.

AU - Moratto, D.

AU - Badolato, R.

AU - Boniotto, M.

AU - Pirulli, D.

AU - Notarangelo, L. D.

AU - Andolina, M.

PY - 2002

Y1 - 2002

N2 - Immune dysregulation, polyendocrinopathy and enteropathy with X-linked inheritance (IPEX) is a serious disease arising from mutations in FOXP3. This gene codifies for a transcription factor whose dysfunction results in hyperactivation of T cells. It is not clear, however, why an intermediate phenotype is not seen in heterozygous females, who are completely healthy. In order to address this question, we investigated X-chromosome inactivation in peripheral blood lymphocytes from a heterozygous female with a child affected by IPEX. No preferential inactivation was shown in freshly sorted CD4+, CD8+, CD19+ cells or in IL-2 cultured CD4 and CD8 T cells, indicating that peripheral blood lymphocytes in these women are randomly selected. Moreover, only one single FOXP3 transcript was expressed by CD4 T cell clones analysed by RT-PCR, confirming that this gene is subject to X-inactivation. We hypothesize that hyper-activation of T cell in carriers of FOXP3 mutations is regulated by the presence of normal regulatory T cells.

AB - Immune dysregulation, polyendocrinopathy and enteropathy with X-linked inheritance (IPEX) is a serious disease arising from mutations in FOXP3. This gene codifies for a transcription factor whose dysfunction results in hyperactivation of T cells. It is not clear, however, why an intermediate phenotype is not seen in heterozygous females, who are completely healthy. In order to address this question, we investigated X-chromosome inactivation in peripheral blood lymphocytes from a heterozygous female with a child affected by IPEX. No preferential inactivation was shown in freshly sorted CD4+, CD8+, CD19+ cells or in IL-2 cultured CD4 and CD8 T cells, indicating that peripheral blood lymphocytes in these women are randomly selected. Moreover, only one single FOXP3 transcript was expressed by CD4 T cell clones analysed by RT-PCR, confirming that this gene is subject to X-inactivation. We hypothesize that hyper-activation of T cell in carriers of FOXP3 mutations is regulated by the presence of normal regulatory T cells.

KW - FOXP3

KW - IPEX

KW - T lymphocytes

KW - X-chromosome inactivation

UR - http://www.scopus.com/inward/record.url?scp=0036379775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036379775&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2249.2002.01940.x

DO - 10.1046/j.1365-2249.2002.01940.x

M3 - Article

VL - 130

SP - 127

EP - 130

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 1

ER -